These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21291297)

  • 1. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
    Danielyan L; Schäfer R; von Ameln-Mayerhofer A; Bernhard F; Verleysdonk S; Buadze M; Lourhmati A; Klopfer T; Schaumann F; Schmid B; Koehle C; Proksch B; Weissert R; Reichardt HM; van den Brandt J; Buniatian GH; Schwab M; Gleiter CH; Frey WH
    Rejuvenation Res; 2011 Feb; 14(1):3-16. PubMed ID: 21291297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.
    Danielyan L; Beer-Hammer S; Stolzing A; Schäfer R; Siegel G; Fabian C; Kahle P; Biedermann T; Lourhmati A; Buadze M; Novakovic A; Proksch B; Gleiter CH; Frey WH; Schwab M
    Cell Transplant; 2014; 23 Suppl 1():S123-39. PubMed ID: 25302802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.
    Wang F; Yasuhara T; Shingo T; Kameda M; Tajiri N; Yuan WJ; Kondo A; Kadota T; Baba T; Tayra JT; Kikuchi Y; Miyoshi Y; Date I
    BMC Neurosci; 2010 Apr; 11():52. PubMed ID: 20420688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
    Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson's disease.
    Kang EJ; Lee YH; Kim MJ; Lee YM; Kumar BM; Jeon BG; Ock SA; Kim HJ; Rho GJ
    J Tissue Eng Regen Med; 2013 Mar; 7(3):169-82. PubMed ID: 22081626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of differentiated human umbilical cord-derived mesenchymal stem cells transplantation on rat model of advanced parkinsonism.
    Wang Z; Chen A; Yan S; Li C
    Cell Biochem Funct; 2016 Aug; 34(6):387-93. PubMed ID: 27558074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
    Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
    J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.
    Fu W; Zheng Z; Zhuang W; Chen D; Wang X; Sun X; Wang X
    Int J Neurosci; 2013 Dec; 123(12):883-91. PubMed ID: 23768098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.
    Suzuki S; Kawamata J; Iwahara N; Matsumura A; Hisahara S; Matsushita T; Sasaki M; Honmou O; Shimohama S
    Neurosci Lett; 2015 Jan; 584():276-81. PubMed ID: 25449872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
    Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of allogeneic bone marrow derived mesenchymal stromal cell therapy on voiding function in a rat model of Parkinson disease.
    Campeau L; Soler R; Sittadjody S; Pareta R; Nomiya M; Zarifpour M; Opara EC; Yoo JJ; Andersson KE
    J Urol; 2014 Mar; 191(3):850-9. PubMed ID: 23973520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease.
    Lu L; Zhao C; Liu Y; Sun X; Duan C; Ji M; Zhao H; Xu Q; Yang H
    Brain Res Brain Res Protoc; 2005 May; 15(1):46-51. PubMed ID: 15878150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic-primed fetal liver mesenchymal stromal-like cells can reverse parkinsonian symptoms in 6-hydroxydopamine-lesioned mice.
    Kumar A; Dudhal S; Sundari T A; Sunkara M; Usman H; Varshney A; Mukhopadhyay A
    Cytotherapy; 2016 Mar; 18(3):307-19. PubMed ID: 26857226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
    Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V; Bibancos T; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.